• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Celator Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011 Product Image

Celator Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011

  • Published: December 2011
  • 61 pages
  • Global Markets Direct

Celator Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Celator Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides data on the Celator Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Celator Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Celator Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Celator Pharmaceuticals, Inc. - Brief Celator Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Celator Pharmaceuticals, Inc.



List of Tables
List of Figures
Celator Pharmaceuticals, Inc. Snapshot
Celator Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Celator Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Celator Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Celator Pharmaceuticals, Inc. – Pipeline Products Glance
Celator Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Celator Pharmaceuticals, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Celator Pharmaceuticals, Inc. – Drug Profiles
CPX-1
Product Description
Mechanism of Action
R&D Progress
CPX-351
Product Description
Mechanism of Action
R&D Progress
CPX-351 + Azacytidine
Product Description
Mechanism of Acti

Note: Product cover images may vary from those shown

RELATED PRODUCTS